PSYENCE BIOMEDICAL LTD Cash Flows From Used In Financing Activities
PSYENCE BIOMEDICAL LTD (PBM) reported Cash Flows From Used In Financing Activities of $7.06 million for the 6-month period ending 2025-09-30, per its 6-K filed 2025-11-20.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:CashFlowsFromUsedInFinancingActivities · last filed 2025-11-20
| Period end | Cash Flows From Used In Financing Activities 6 month | Cash Flows From Used In Financing Activities 12 month |
|---|---|---|
| 2025-09-30 | $7.06M 6-K · filed 2025-11-20 | |
| 2025-03-31 | $9.15M 20-F · filed 2025-06-25 | |
| 2024-09-30 | $2.72M 6-K · filed 2025-11-20 | |
| 2024-03-31 | $2.35M 20-F · filed 2025-06-25 | |
| 2023-09-30 | $859.34K 6-K · filed 2025-01-23 | |
| 2023-03-31 | $1.17M 20-F · filed 2025-06-25 |